Top

Published in:

Open Access 01-12-2022 | Lymphedema | Commentary

Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies

Authors: Jie Deng, John N. Lukens, Joy C. Cohn, Erin McMenamin, Barbara Murphy, Bryan A. Spinelli, Niya Murphy, Alicia K. Steinmetz, Megan A. Landriau, Alexander Lin

Published in: Trials | Issue 1/2022

Abstract

The coronavirus disease 2019 (COVID-19) pandemic resulted in severe interruptions to clinical research worldwide. This global public health crisis required investigators and researchers to rapidly develop and implement new strategies and solutions to mitigate its negative impact on the progress of clinical trials. In this paper, we describe the challenges, strategies, and lessons learned regarding the continuation of a supportive oncology clinical trial during the pandemic. We hope to provide insight into the implementation of clinical trials during a public health emergency to be better prepared for future instances.

Trial registration: ClinicalTrials.gov, a service of the US National Institute of Health (NCT 03030859). Registered on 22 January 2017.

Impact of COVID-19 on people’s livelihoods, their health and our food systems - joint statement by ILO, FAO, IFAD and WHO. Available from: https://www.who.int/news/item/13-10-2020-impact-of-covid-19-on-people's-livelihoods-their-health-and-our-food-systems. Accessed 10 Aug 2020.

Sathian B, Asim M, Banerjee I, Pizarro AB, Roy B, van Teijlingen ER, et al. Impact of COVID-19 on clinical trials and clinical research: a systematic review. Nepal J Epidemiol. 2020;10(3):878–87. https://doi.org/10.3126/nje.v10i3.31622.CrossRefPubMedPubMedCentral

FDA Guidance on conduct of clinical trials of medical products during the COVID-19 public health emergency - guidance for industry, investigators, and institutional review boards (March 2020). U.S. Food & Drug Administration. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency. Accessed 10 Aug 2021.

Nishiwaki S, Ando Y. COVID-19 pandemic and trends in clinical trials: a multi-region and global perspective. Front Med (Lausanne). 2021;8:812370. https://doi.org/10.3389/fmed.2021.812370 PMID: 35004791; PMCID: PMC8739772.CrossRef

ClinicalTrials.Gov. Self-care for head and neck cancer survivors with lymphedema and fibrosis. U.S. NIH; 2017. Available from: https://clinicaltrials.gov/ct2S/show/NCT03030859. Accessed 10 Aug 2021.

Deng J, Dietrich MS, Murphy B. Self-care for head and neck cancer survivors with lymphedema and fibrosis: study protocol for a randomized controlled trial. Trials. 2019;20(1):775. https://doi.org/10.1186/s13063-019-3819-0 PMID: 31882012; PMCID: PMC6935145.CrossRefPubMedPubMedCentral

Penn Medicine updated clinical research guidance in relation to COVID-19 (corona virus) (March 13, 2020). Available from: https://irb.upenn.edu/announcements/penn-medicine-updated-clinical-research-guidance-relation-covid-19-corona-virus. Accessed 12 Aug 2021.

City issues stay at home order clarifying restrictions on business activity in Philadelphia (March 22, 2020). Available from: https://www.phila.gov/2020-03-22-city-issues-stay-at-home-order-clarifying-restrictions-on-business-activity-in-philadelphia/. Accessed 12 Aug 2021.

Audisio K, Lia H, Robinson NB, Rahouma M, Soletti G Jr, Cancelli G, et al. Impact of the COVID-19 pandemic on non-COVID-19 clinical trials. J Cardiovasc Dev Dis. 2022;9(1):19. https://doi.org/10.3390/jcdd9010019.CrossRefPubMedPubMedCentral

10.

Deng J, Lukens JN, Swisher-McClure S, Cohn JC, Spinelli B, Quinn RJ, et al. Photobiomodulation therapy in head and neck cancer-related lymphedema: a pilot feasibility study. Integr Cancer Ther. 2021;20:15347354211037938. https://doi.org/10.1177/15347354211037938 PMID: 34387119.CrossRefPubMedPubMedCentral

Title: Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies
Authors: Jie Deng
John N. Lukens
Joy C. Cohn
Erin McMenamin
Barbara Murphy
Bryan A. Spinelli
Niya Murphy
Alicia K. Steinmetz
Megan A. Landriau
Alexander Lin
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Lymphedema
COVID-19
Telemedicine
Published in: Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-022-06804-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial

Assessing the effectiveness of a LGBT cultural competency training for oncologists: study protocol for a randomized pragmatic trial

Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial

Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial

Optimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial

Effects of a smartphone app-augmented treatment for children with oppositional defiant disorder / conduct disorder and peer-related aggressive behavior – a pilot study